Home › Investor Overview
As of May 2013, Angiotech will no longer be a voluntary filer of its financial information with the U.S. Securities and Exchange Commission, and going forward Angiotech will be a fully private company. If you are a current Angiotech shareholder and have questions, or you would like to receive our most recent quarterly financial information, please email firstname.lastname@example.org with your name and the name of your agent, if applicable. Please be advised that we will ONLY send information to current shareholders, and only to the address as provided on the current share registry at the time of the mailing.
Welcome to Angiotech's Investor Relations section. Use the navigation menu on the left to find up-to-date corporate financial information. Some other helpful links include:
Important Financial Release Dates
- Q1 : Tuesday, May 15, 2012
- Q2 : Wednesday, August 15, 2012
- Q3 : Thursday, November 15, 2012
- Q4 and Year End : TBA
Investor Relations Contacts
Investors, security analysts and representatives of portfolio management firms may contact:
- tel: (604) 221-7933
- email: email@example.com.
- Investor Overview
- Corporate Governance
- Events & Webcasts
- Quarterly Results
- Proxy Materials
- SEC Filings
© Copyright 2011 Angiotech. All Rights Reserved.